RadNet, Inc. (RDNT) Financials

RDNT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.9 billion 2.1 billion
2023-09-30 2.7 billion 1.9 billion
2023-06-30 2.7 billion 1.9 billion
2023-03-31 2.4 billion 1.9 billion

RDNT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 48.9 million 5.4 million
2023-09-30 -9.9 million 4.3 million
2023-06-30 38.3 million 4.9 million
2023-03-31 -32.9 million 12.2 million

RDNT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -1.9 million
2023-09-30 24.1 million
2023-06-30 14.6 million
2023-03-31 -14.3 million

RDNT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 342.6 million - 661.1 million
2023-09-30 337.9 million - 673.4 million
2023-06-30 356.7 million - 688.3 million
2023-03-31 90.8 million - 682.1 million

RDNT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 67.9 million
2023-09-30 68.8 million
2023-06-30 60.9 million
2023-03-31 57.7 million

RDNT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 40.1 million - - -
2023-09-30 41.2 million - - -
2023-06-30 29.8 million - 347.0 million -
2023-03-31 65.6 million - 352.0 million -

RDNT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 420.4 million 389.3 million
2023-09-30 402.0 million 341.6 million
2023-06-30 403.7 million 345.1 million
2023-03-31 390.6 million 351.9 million

RDNT

Price: $48.40

52 week price:
25.11
49.94

Payout Ratio Range:
-22400.00%
4890.83%

Earnings Per Share: 0.05 USD

P/E Ratio: 638.67

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 93400

Ebitda: 32.2 million

Market Capitalization: 3.6 billion

Links: